Proteostasis Therapeutics
is engaged in developing small molecule drugs to treat neurodegenerative, genetic and inflammatory disorders... Read moreProteostasis Therapeutics
is engaged in developing small molecule drugs to treat neurodegenerative, genetic and inflammatory disorders... Read more
News
Aug 26, 2021
PharmaLeaders
Proteostasis Therapeutics: Q&A: Mark Enyedy, ImmunoGen
Dec 23, 2020
Boston Citybizlist
Proteostasis Therapeutics: Yumanity Therapeutics Completes Reverse Merger with Proteostasis Therapeutics
Dec 22, 2020
BioSpace
Proteostasis Therapeutics: Proteostasis Therapeutics, Inc. Stockholders Approve Business Combination with Yumanity Therapeutics, Inc.; Board Sets Reverse Stock Split Ratio
Dec 16, 2020
BioSpace
Proteostasis Therapeutics: Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
Dec 15, 2020
GlobeNewswire
Press Release: Proteostasis Therapeutics : Yumanity Therapeutics to Raise $33.6 Million PIPE Contingent on Completion of Reverse Merger with Proteostasis
Nov 16, 2020
BioSpace
Proteostasis Therapeutics: Proteostasis Therapeutics Reports Third Quarter 2020 Financial Results
Nov 16, 2020
St Louis Post Dispatch
Proteostasis Therapeutics: Proteostasis: 3Q Earnings Snapshot
Nov 16, 2020
Law.com
Press Release: Proteostasis Therapeutics : Kaskela Law LLC Announces Investigation of Proteostasis Therapeutics, Inc. (PTI) and Encourages PTI Shareholders to Contact the Firm
Oct 17, 2020
Micro Small Cap
Proteostasis Therapeutics: INVESTIGATION ALERT: Halper Sadeh LLP is Investigating the Following Companies; Investors are Encouraged to Contact the Firm - GLIBA, PTI, MR, CBMG
Oct 06, 2020
MarketScreener
Proteostasis Therapeutics: SHAREHOLDER ALERT: WeissLaw LLP Reminds PTI and NETE Shareholders About Its Ongoing Investigations
Proteostasis Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10